Proposed MolDX LCDs

When there are Proposed Local Coverage Determinations (LCDs) that are in the comment period, this webpage will provide a summary of comments received and Noridian's response. This information will remain on this webpage for at least six months.

Status Indicators

D = Proposed under development, not yet released for comment
C = Proposed MolDX LCD released for comment
E = Formal comment period has ended; comments now being considered
F = Final new/revised MolDX LCD has been issued for notice
A = Active policy: notice period complete and the policy is in effect

Send Proposed MolDX LCD Comments to:

Mail:
Noridian Medicare JF Part A
Attention: Proposed LCD Comments
PO Box 6781
Fargo, ND 58108-6781
Email: policydraft@noridian.com

 
Proposed LCD and Billing and Coding Article Title Release Date of Proposed LCD for Comment End Date for Comment Period Current Status Comments / Responses Date of Release for Notice Link to Final LCD
MolDX: Biomarker Testing for Risk Stratification in DCIS 07/17/25 08/31/25 C      
MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis

Billing and Coding: MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis		 08/28/25 10/12/25 C      
MolDX: Genetic Testing for Heritable Thoracic Aortic Disease

Billing and Coding: MolDX: Genetic Testing in Heritable Thoracic Aortic Disease		 08/29/24 10/12/24 F View 08/17/25 View
MolDX: Genetic Testing for Hereditary Thrombophilia

Billing and Coding: MolDX: Genetic Testing for Hereditary Thrombophilia		 08/28/25 10/12/25 C      
MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis

Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis		 08/29/24 10/12/24 F View 08/17/25 View
MolDX: Molecular Testing for Solid Organ Allograft Rejection

Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection		 07/17/25 08/31/25 C  
MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer

Billing and Coding: MolDX: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer		 08/28/25 10/12/25 C      
MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms

Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms		 08/01/24 09/15/24 F View 08/17/25 View
Last Updated Aug 28 , 2025